|
|
|
|
|
by Fordrus
3633 days ago
|
|
An antibiotic discovery startup, eh? That's freaking fascinating, I'm in bioinformatics myself, I'd love to hear more about this- I wasn't aware that an antibiotic discovery startup was/is/could be a thing at all- If you can tell me anything more or put me on the right track to reading more about your old employer in that space or whatnot, I'd appreciate it! :) |
|
But these startups do exist: look up Achaogen (achaogen.com) and Tetraphase (tphase.com).
Cubist Pharmaceuticals was a big antibiotic developer that was recently purchased by Merck. Cubist itself bought another startup called Trius Pharmaceuticals, which had developed a newly marketed antibiotic.
So, there is $$ to be made in antibiotic drug development, but as many people on this thread have pointed out, there is more $$$$ to be made in other therapeutic areas (e.g., oncology).